Who Paid My Doc
Shilpa Pandey
Pediatric Pulmonology Orlando, FL Medical Doctor
NPI 1295915171 CMS profile 2791126
2813 S Hiawassee Rd Ste 303, Orlando, FL 32835
General payments
$3,016
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Shilpa Pandey of Orlando, FL is reported in the CMS Open Payments database as having received $3,016 across 27 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 80th percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $264 | 9 | |
| 2024 | General | $506 | 6 | |
| 2022 | General | $1,773 | 2 | |
| 2021 | General | $125 | 1 | |
| 2020 | General | $142 | 3 | |
| 2019 | General | $206 | 6 |
Beside peers
- Shilpa Pandey
- Pediatric Pulmonology median
- Middle half of Pediatric Pulmonology
- National median
In program year 2025, general payments to Shilpa Pandey were reported at $264. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.
Show as a table
| Year | Shilpa Pandey | Pediatric Pulmonology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $206 | $151 | $59–$495 | $163 |
| 2020 | $142 | $107 | $34–$339 | $114 |
| 2021 | $125 | $125 | $40–$511 | $132 |
| 2022 | $1,773 | $133 | $49–$428 | $149 |
| 2023 | $0 | $138 | $44–$494 | $160 |
| 2024 | $506 | $132 | $46–$398 | $164 |
| 2025 | $264 | $139 | $60–$405 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 11 billing codesPaid by Medicare
$6,572
Medicare patients
19
Services billed
65
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 74% | |
| Cancer | 0% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
27 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Pulmonology in Florida
Akinyemi Ajayi
Pediatric Pulmonology · Winter Park, FL
John Prpich
Pediatric Pulmonology · Tampa, FL
Floyd Livingston
Pediatric Pulmonology · Orlando, FL
Aledie Navas
Pediatric Pulmonology · Orlando, FL
Kunjana Mavunda
Pediatric Pulmonology · South Miami, FL
David Rosenberg
Pediatric Pulmonology · Tampa, FL
Related records
Pediatric Pulmonology in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Pulmonology
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.